Banque Transatlantique’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$163K Buy
2,040
+333
+20% +$21.9K ﹤0.01% 297
2026
Q1
$122K Sell
1,707
-333
-16% -$26.3K ﹤0.01% 267
2025
Q4
$167K Sell
2,040
-44
-2% -$3.43K ﹤0.01% 129
2025
Q3
$156K Buy
2,084
+1,408
+208% +$105K ﹤0.01% 130
2025
Q2
$50.3K Sell
676
-41
-6% -$2.85K ﹤0.01% 154
2025
Q1
$57.8K Sell
717
-105
-13% -$9.02K ﹤0.01% 138
2024
Q4
$63.9K Buy
+822
New +$69.9K ﹤0.01% 151

Other funds holding GEHC

Banque Transatlantique's GEHC Position: Q2 2026 in Review

Banque Transatlantique increased its GE HealthCare (GEHC) stake by 20% in Q2 2026, buying an estimated $21.9K and bringing the position to 2,040 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #297.

Banque Transatlantique first reported a position in GEHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $167K in Q4 2025. 702 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Banque Transatlantique held 2,040 shares of GE HealthCare worth $163K as of Q2 2026.
  • Banque Transatlantique bought 333 GE HealthCare shares in Q2 2026, an estimated $21.9K.
  • GE HealthCare made up ﹤0.01% of Banque Transatlantique's portfolio in Q2 2026, its #297 holding.
  • Banque Transatlantique first reported a position in GE HealthCare in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's GE HealthCare position peaked at $167K in Q4 2025.
  • 702 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.